XML 39 R28.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 3 - Balance Sheet Components - Schedule Of Other Assets (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022
--- | --- | ---
Prepaid clinical trial costs (noncurrent portion) | $ 1,106,778 | $ 2,083,276
Prepaid technology license fees | 70,000 | 80,000
Deposits | 11,010 | 11,010
Total other assets | $ 1,187,788 | $ 2,174,286

X
- Definition Amount of prepaid clinical trial expenses after the next 12 months + References No definition available. + Details
Name: | govx_PrepaidClinicalTrialExpensesNoncurrent
Namespace Prefix: | govx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents prepaid technology license fees. + References No definition available. + Details
Name: | govx_PrepaidTechnologyLicenseFees
Namespace Prefix: | govx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of noncurrent assets classified as other. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_OtherAssetsNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_SecurityDeposit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant